Open AccessA profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection
Author(s) -
YuJun Dai,
Fang Hu,
Huan Li,
Hanying Huang,
Dawei Wang,
Yang Liang
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2020.03.61
Subject(s) - hepatocellular carcinoma , coronavirus , virus , pneumonia , gene expression profiling , biology , receptor , covid-19 , medicine , virology , immunology , cancer research , disease , gene , gene expression , infectious disease (medical specialty) , genetics
We indeed emphasized that LIHC patients with high expression level of ACE2 should be more cautious of the virus infection. Our study might provide a potential clue for preventing infection of SARS-CoV-2 in cancers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom